Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Regado Biosciences Inc.
Fiscal year is January-December. All values USD millions. 2011 2012 2013 5-year trend
Sales/Revenue - - 0 0 0
Cost of Goods Sold (COGS) incl. D&A - - 470,000 412,000 81,000
COGS excluding D&A - - 0 0 0
Depreciation & Amortization Expense - - 470,000 412,000 81,000
Depreciation - - 131,000 11,000 61,000
Amortization of Intangibles - - 339,000 401,000 20,000
Gross Income - - (470,000) (412,000) (81,000)
2011 2012 2013 5-year trend
SG&A Expense - - 18.35M 11.73M 32.72M
Research & Development - - 11.86M 5.31M 25.84M
Other SG&A - - 6.49M 6.42M 6.88M
Other Operating Expense - - 0 0 0
Unusual Expense - - 83,452 22,377 978,000
EBIT after Unusual Expense - - (83,452) (22,377) (978,000)
Non Operating Income/Expense - - 0 0 0
Non-Operating Interest Income - - 7,000 5,000 11,000
Equity in Affiliates (Pretax) - - 0 0 -
Interest Expense - - 301,000 904,000 671,000
Gross Interest Expense - - 301,000 904,000 671,000
Interest Capitalized - - 0 0 0
Pretax Income - - (19.2M) (13.06M) (34.44M)
Income Tax - - 0 0 0
Income Tax - Current Domestic - - 0 0 -
Income Tax - Current Foreign - - 0 0 -
Income Tax - Deferred Domestic - - 0 0 -
Income Tax - Deferred Foreign - - 0 0 -
Income Tax Credits - - 0 0 -
Equity in Affiliates - - 0 0 -
Other After Tax Income (Expense) - - 0 0 0
Consolidated Net Income - - (19.2M) (13.06M) (34.44M)
Minority Interest Expense - - 0 0 0
Net Income - - (19.2M) (13.06M) (34.44M)
Extraordinaries & Discontinued Operations - - 0 0 0
Extra Items & Gain/Loss Sale Of Assets - - 0 0 0
Cumulative Effect - Accounting Chg - - 0 0 0
Discontinued Operations - - 0 0 0
Net Income After Extraordinaries - - (19.2M) (13.06M) (34.44M)
Preferred Dividends - - 0 0 0
Net Income Available to Common - - (19.2M) (13.06M) (34.44M)
EPS (Basic) - - (3.07) (1.88) (4.59)
Basic Shares Outstanding - - 6.25M 6.95M 7.5M
EPS (Diluted) - - (3.07) (1.88) (4.59)
Diluted Shares Outstanding - - 6.25M 6.95M 7.5M
EBITDA - - (18.35M) (11.73M) (32.72M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.